706 results on '"Garaventa, Alberto"'
Search Results
2. Measurement of 3-O-methyldopa from dried plasma microsamples by high-resolution mass spectrometry: A tool for the diagnosis of patients with high-risk neuroblastoma
3. Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding
4. Computational intelligence analysis of high-risk neuroblastoma patient health records reveals time to maximum response as one of the most relevant factors for outcome prediction
5. 131I-MIBG Therapy of Malignant Neuroblastoma and Pheochromocytoma
6. Resection of primary tumor in stage 4S neuroblastoma: a second study by the Italian Neuroblastoma Group
7. Reaching the target dose with one single 131I‐mIBG administration in high‐risk neuroblastoma: The determinant impact of the primary tumour
8. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
9. Plasma free metanephrines for diagnosis of neuroblastoma patients
10. Reaching the target dose with one single 131I‐mIBG administration in high‐risk neuroblastoma: The determinant impact of the primary tumour.
11. Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients
12. Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma
13. The unusual association between Neuroblastoma and Gaucher Disease: Case report and review of the literature
14. FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial
15. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
16. Pediatric Extraskeletal Ewing Sarcoma Originating in the Heart: A Case Report and Review of the Literature
17. Abstract 3407: The italian personalized medicine program PREME for high-risk neuroblastoma
18. Data from Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
19. Supplementary Methods, Figures 1-4, Tables 1-3 from Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
20. Neuroblastoma (Peripheral neuroblastic tumours)
21. Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology
22. Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues
23. Nucleolin expression has prognostic value in neuroblastoma patients
24. Prospective Evaluation of Different Methods for Volumetric Analysis on [18F]FDG PET/CT in Pediatric Hodgkin Lymphoma
25. Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations
26. Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
27. Congenital Myoepithelial Carcinoma of Soft Tissue Associated With Cystic Myoepithelioma
28. Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An 18F‐DOPA PET study
29. Abstract 1276: Nucleolin has prognostic value in neuroblastoma patients
30. Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
31. Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real‐life study
32. Outcome of children with relapsed or refractory neuroblastoma: A meta‐analysis of ITCC/SIOPEN European phase II clinical trials
33. Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials
34. Osteogenesis Imperfecta/Ehlers–Danlos Overlap Syndrome and Neuroblastoma—Case Report and Review of Literature
35. Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience
36. Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels
37. Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma
38. Laparoscopic resection of adrenal neuroblastoma without image-defined risk factors: a prospective study on 21 consecutive pediatric patients
39. Facing Thyroid Nodules in Paediatric Patients Previously Treated with Radiotherapy for Non-Thyroidal Cancers: Are Adult Ultrasound Risk Stratification Systems Reliable?
40. Non-Hodgkin Lymphoma in Children With an Associated Inherited Condition: A Retrospective Analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
41. Genetic Abnormalities in Adolescents and Young Adults With Neuroblastoma: A Report From the Italian Neuroblastoma Group
42. Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma
43. Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An 18F‐DOPA PET study.
44. Prospective Evaluation of Different Methods for Volumetric Analysis on [ 18 F]FDG PET/CT in Pediatric Hodgkin Lymphoma.
45. Second Malignancies in Children Following Treatment for Neuroblastoma
46. Contributors
47. Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study
48. Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma
49. Additional file 5 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
50. Additional file 3 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.